Stryker invests about $400M in CMR Surgical, with an option to buy the rest

The Robot Report said on 15 October 2026 that Stryker has invested about $400 million in CMR Surgical, with an exclusive option to acquire the company's remaining equity, and has secured an exclusive US commercial agency agreement for the Versius surgical-robot portfolio. Cambridge, UK-based CMR Surgical says it designed Versius to be compact and modular, so it does not require a dedicated operating room.

What it means A major device maker taking a route to own a surgical-robot platform raises the competitive stakes in robotic surgery, especially in the US.